Results 91 to 100 of about 36,452 (164)

A case of corneal opacity caused by atovaquone administration

open access: yesAmerican Journal of Ophthalmology Case Reports
Purpose: Atovaquone is an alternative drug that is used for the prevention and treatment of Pneumocystis pneumonia when the first-line drug, sulfamethoxazole-trimethoprim (ST combination), cannot be used due to side effects.
Takeyoshi Ashizuka   +6 more
doaj   +1 more source

Duration of antibacterial treatment for uncomplicated urinary tract infection in women [PDF]

open access: yes, 2005
BAERHEIM, A   +5 more
core   +1 more source

Hospital acquired drug resistant pathogens infections in patients with viral respiratory tract infections: a retrospective study

open access: yesBMC Infectious Diseases
Background Viral respiratory infections (VRTIs) caused by influenza (Flu) and COVID-19 pose significant global health challenges. Clinical outcomes are further exacerbated by infections with hospital acquired drug resistant pathogens (DRPs).
Zibo Fan   +10 more
doaj   +1 more source

CycP: A Novel Self-Assembled Vesicle-Forming Cyclic Antimicrobial Peptide to Control Drug-Resistant S. aureus

open access: yesBioengineering
Antimicrobial peptides (AMPs) are considered a promising alternative to conventional antibiotics to fight against the rapid evolution of antibiotic resistance.
Piyush Baindara   +2 more
doaj   +1 more source

Successful Treatment of Disseminated Nocardiosis Complicated by Cerebral Abscess with Ceftriaxone and Amikacin: Case Report [PDF]

open access: yes, 2017
We report the case of an 85-year-old female patient who suffered from disseminated Nocardia asteroides infection complicated by a cerebral abscess. Treatment with amikacin for 2 weeks and ceftriaxone for 6 weeks led to complete recovery, and there was no
Bodmer, T.   +4 more
core  

Combination Therapy of Trimethoprim-Sulfamethoxazole (TMP-SMZ) and Eravacycline for Treating Elizabethkingia anophelis-Induced Pulmonary Infections: A Case Report

open access: yesInfection and Drug Resistance
Qimei Wei,1,* Wenxia Zuo,2,* Rong Cong,1 Kun Luo,1 Shanshan Dong1 1Department of Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan, 430022, People’s Republic of China; 2Department of Cardiac Critical Care Medicine, Wuhan Asia Heart Hospital ...
Wei Q, Zuo W, Cong R, Luo K, Dong S
doaj  

Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection

open access: yesBulletin of the World Health Organization, 2004
Infants with HIV infection are vulnerable to Pneumocystis carinii pneumonia (PCP) during their first year of life. WHO and the Joint United Nations Programme on HIV/AIDS now recommend that all children of HIV-positive mothers receive prophylactic ...
Gill Christopher J.   +3 more
doaj  

Home - About - Disclaimer - Privacy